Literature DB >> 27528075

Myosin light chain kinase steady-state kinetics: comparison of smooth muscle myosin II and nonmuscle myosin IIB as substrates.

Diego B Alcala1, Brian D Haldeman1, Richard K Brizendine1, Agata K Krenc2, Josh E Baker1, Ronald S Rock2, Christine R Cremo3.   

Abstract

Myosin light chain kinase (MLCK) phosphorylates S19 of the myosin regulatory light chain (RLC), which is required to activate myosin's ATPase activity and contraction. Smooth muscles are known to display plasticity in response to factors such as inflammation, developmental stage, or stress, which lead to differential expression of nonmuscle and smooth muscle isoforms. Here, we compare steady-state kinetics parameters for phosphorylation of different MLCK substrates: (1) nonmuscle RLC, (2) smooth muscle RLC, and heavy meromyosin subfragments of (3) nonmuscle myosin IIB, and (4) smooth muscle myosin II. We show that MLCK has a ~2-fold higher kcat for both smooth muscle myosin II substrates compared with nonmuscle myosin IIB substrates, whereas Km values were very similar. Myosin light chain kinase has a 1.6-fold and 1.5-fold higher specificity (kcat /Km ) for smooth versus nonmuscle-free RLC and heavy meromyosin, respectively, suggesting that differences in specificity are dictated by RLC sequences. Of the 10 non-identical RLC residues, we ruled out 7 as possible underlying causes of different MLCK kinetics. The remaining 3 residues were found to be surface exposed in the N-terminal half of the RLC, consistent with their importance in substrate recognition. These data are consistent with prior deletion/chimera studies and significantly add to understanding of MLCK myosin interactions. SIGNIFICANCE OF THE STUDY: Phosphorylation of nonmuscle and smooth muscle myosin by myosin light chain kinase (MLCK) is required for activation of myosin's ATPase activity. In smooth muscles, nonmuscle myosin coexists with smooth muscle myosin, but the two myosins have very different chemo-mechanical properties relating to their ability to maintain force. Differences in specificity of MLCK for different myosin isoforms had not been previously investigated. We show that the MLCK prefers smooth muscle myosin by a significant factor. These data suggest that nonmuscle myosin is phosphorylated more slowly than smooth muscle myosin during a contraction cycle.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  myosin light chain kinase; myosin regulatory light chain; nonmuscle myosin; phosphorylation; smooth muscle; smooth muscle myosin; steady-state kinetics

Mesh:

Substances:

Year:  2016        PMID: 27528075      PMCID: PMC5076371          DOI: 10.1002/cbf.3209

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  52 in total

1.  Kinetic mechanism of non-muscle myosin IIB: functional adaptations for tension generation and maintenance.

Authors:  Fei Wang; Mihaly Kovacs; Aihua Hu; John Limouze; Estelle V Harvey; James R Sellers
Journal:  J Biol Chem       Date:  2003-04-17       Impact factor: 5.157

2.  Cloning and characterization of a vertebrate cellular myosin regulatory light chain complementary DNA.

Authors:  P J Zavodny; M E Petro; H K Lonial; S H Dailey; S K Narula; P J Leibowitz; C C Kumar
Journal:  Circ Res       Date:  1990-10       Impact factor: 17.367

3.  The kinetics underlying the velocity of smooth muscle myosin filament sliding on actin filaments in vitro.

Authors:  Brian D Haldeman; Richard K Brizendine; Kevin C Facemyer; Josh E Baker; Christine R Cremo
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

4.  A single human myosin light chain kinase gene (MLCK; MYLK).

Authors:  V Lazar; J G Garcia
Journal:  Genomics       Date:  1999-04-15       Impact factor: 5.736

5.  A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans.

Authors:  Carlos Flores; Shwu-Fan Ma; Karen Maresso; Carole Ober; Joe G N Garcia
Journal:  Genet Epidemiol       Date:  2007-05       Impact factor: 2.135

6.  Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease.

Authors:  Stephanie A Blair; Sunanda V Kane; Daniel R Clayburgh; Jerrold R Turner
Journal:  Lab Invest       Date:  2006-02       Impact factor: 5.662

7.  Myosin light chain kinase is necessary for tonic airway smooth muscle contraction.

Authors:  Wen-Cheng Zhang; Ya-Jing Peng; Gen-Sheng Zhang; Wei-Qi He; Yan-Ning Qiao; Ying-Ying Dong; Yun-Qian Gao; Chen Chen; Cheng-Hai Zhang; Wen Li; Hua-Hao Shen; Wen Ning; Kristine E Kamm; James T Stull; Xiang Gao; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

8.  A new method to specifically label thiophosphorylatable proteins with extrinsic probes. Labeling of serine-19 of the regulatory light chain of smooth muscle myosin.

Authors:  K C Facemyer; C R Cremo
Journal:  Bioconjug Chem       Date:  1992 Sep-Oct       Impact factor: 4.774

9.  Ragweed sensitization-induced increase of myosin light chain kinase content in canine airway smooth muscle.

Authors:  H Jiang; K Rao; A J Halayko; X Liu; N L Stephens
Journal:  Am J Respir Cell Mol Biol       Date:  1992-12       Impact factor: 6.914

10.  Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.

Authors:  Liping Su; Le Shen; Daniel R Clayburgh; Sam C Nalle; Erika A Sullivan; Jon B Meddings; Clara Abraham; Jerrold R Turner
Journal:  Gastroenterology       Date:  2008-11-06       Impact factor: 22.682

View more
  5 in total

1.  Prenatal metyrapone treatment modulates neonatal cerebrovascular structure, function, and vulnerability to mild hypoxic-ischemic injury.

Authors:  P Naomi Franco; Lara M Durrant; Desirelys Carreon; Elizabeth Haddad; Adam Vergara; Catherine Cascavita; Andre Obenaus; William J Pearce
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

2.  ML-7 attenuates airway inflammation and remodeling via inhibiting the secretion of Th2 cytokines in mice model of asthma.

Authors:  Chuanjun Huang; Zewen Zhang; Liuxin Wang; Ju Liu; Xiaodan Gong; Caiqing Zhang
Journal:  Mol Med Rep       Date:  2018-03-06       Impact factor: 2.952

3.  Maternal Undernutrition Modulates Neonatal Rat Cerebrovascular Structure, Function, and Vulnerability to Mild Hypoxic-Ischemic Injury via Corticosteroid-Dependent and -Independent Mechanisms.

Authors:  Patsy Naomi Franco; Lara M Durrant; Coleen Doan; Desirelys Carreon; Alejandra Beltran; Amandine Jullienne; Andre Obenaus; William J Pearce
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

4.  Hypoxic modulation of fetal vascular MLCK abundance, localization, and function.

Authors:  Dane W Sorensen; Desirelys Carreon; James M Williams; William J Pearce
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-10-28       Impact factor: 3.619

Review 5.  The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction.

Authors:  Olga Soriano; Marta Alcón-Pérez; Miguel Vicente-Manzanares; Esther Castellano
Journal:  Genes (Basel)       Date:  2021-05-27       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.